Copy Number Observer

Front

Welcome to the second edition of Copy Number Observer, in which we bring you the latest information on OGT’s CytoSure family of products and services for the cytogenetics community, including details of our new CytoSure labelling kit.

Spencer

 

This issue features the work and findings of some of our CytoSure™ users, each of which have seen the benefits of switching from BAC to OGT’s oligonucelotide arrays for high resolution aCGH. For example, the Greenwood Genetic Center has applied oligonucleotide aCGH to clinical genetic analysis of patients with chromosomal abnormalities, while Katholieke Universiteit Leuven has used CytoSure arrays for investigating cytogenetic screening at the prenatal and postnatal stages. You can also read about how our in-house automated, high-throughput array processing service has worked for another group of clinical geneticists.

The final article brings you further insight into OGT’s CytoSure analysis software development, and how we introduce new features that further streamline your cytogenetic analysis.

We hope you enjoy this issue, and if you have any ideas or would like input into future editions of OGT’s CNO then please do not hesitate to contact me.

Spencer Howell
Director of Cytogenetics

American College of Medical Genetics Annual Meeting 25th – 29th March Tampa, Florida
20th Conference of the German Society of Human Genetics 1st – 3rd April Aachen, Germany
5th International meeting on Cryptic Chromosomal rearrangements associated with Mental Retardation and Autism 17th – 18th April Troina, Italy
Association of Clinical Cytogenetics Spring Meeting 27th – 28th April Edinburgh, UK
Great Lakes Chromosome Conference 14th – 15th May Toronto, Canada
European Human Genetics Conference 23rd – 26th May Vienna, Austria
Association of Genetic Technologists Annual Meeting 25th – 27th June Jacksonville, Florida
European Cytogenetics Association Conference 4th – 7th July Stockholm, Sweden
American Society of Human Genetics 20th – 24th October Honolulu, Hawaii
For research use only
This product is provided under an agreement between Agilent Technologies, Inc. and OGT. The manufacture, use, sale or import of this product may be subject to one or more of U.S. patents, pending applications, and corresponding international equivalents, owned by Agilent Technologies, Inc. The purchaser has the non-transferable right to use and consume the product for RESEARCH USE ONLY AND NOT for DIAGNOSTICS PROCEDURES. It is not intended for use, and should not be used, for the diagnosis, prevention, monitoring, treatment or alleviation of any disease or condition, or for the investigation of any physiological process, in any identifiable human, or for any other medical purpose.